Rapid Influenza Diagnostic Tests Market Trends (2021-2031)
The Rapid Influenza Diagnostic Tests Market is expected to register a CAGR of 8.4% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Hydraulic, Manual, Electronic). The report further presents analysis based on the Application (Dental Laboratory, Hospital, Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Rapid Influenza Diagnostic Tests Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Rapid Influenza Diagnostic Tests Market Segmentation
Test Type- Influenza A Tests
- Influenza B Test
- Influenza A+B Test
- Nasal Swab
- Throat Swab
- Nasopharyngeal Swab
- Others
- Immunochromatographic Assays
- Immunofluorescence Assays
- Nucleic Acid Amplification Test
- Hospitals and Clinics
- Diagnostic Centers
- Nursing Homes
- Others
- Hospitals and Clinics
- Diagnostic Centers
- Nursing Homes
- Others
Strategic Insights
Rapid Influenza Diagnostic Tests Market Growth Drivers- Rising cases of influenza: The growing prevalence of influenza infections, especially the seasonal outbreaks contribute to the increasing demand for its rapid diagnostic tests. Early and effective treatments of the infection are also needed; accordingly, rapid influenza diagnostic tests have become a key tool that healthcare providers have adopted to improve patient outcomes and improve clinical workflows.
- Technological Advancements: Development in the field of diagnostics, for example, improved, and user-friendly rapid influenza tests, are helping enhance the growth of the market. The advancement leads to quicker results, it is more sensitive, and thus a must-have in clinical and point-of-care settings, with more and more healthcare professionals being on board.
- Increased Awareness and Access: More patient and provider awareness about the importance of early diagnosis of influenza-the primary reason for market growth. More access through retail pharmacies and clinics, ensuring rapid testing, makes their use more likely and enhances public health responses during flu seasons.
- Point-of-Care Testing: The rapid influenza diagnostic tests market goes forward with point-of-care testing. Convenience and speed have been driving healthcare providers to adopt POC tests so that results obtained instantly help them make treatment decisions immediately and can improve patient care as well as resource management in a clinical setting.
- Integration into the Digital Health Trend: Rapid diagnostic tests are increasingly being introduced with digital health technologies, such as mobile applications and telemedicine. It addresses better management of data; remote consultations are taken care of through the integration of medical consultations with patients; it is efficient in monitoring cases of influenza; and overall, it enhances healthcare delivery and engages patients.
- The role of increased government initiative: Increased governmental activities in funding and awareness campaigns boost the usage of rapid influenza diagnostic tests. Such increased initiatives enhance surveillance and control over outbreaks of the flu, hence encouraging the development and delivery of these tests in all public and private facilities.
- Emerging Markets: Rapidly growing healthcare infrastructure in the emerging markets opens vast opportunities for rapid influenza diagnostic tests. More investments by regions in improving healthcare create rising demand for such effective diagnostic tools, opening scope for manufacturers to tap into new markets and customers.
- Combination Tests Development: The combination tests would enable manufacturers to devise tests which can detect more than one agent responsible for respiratory illness, such as influenza, at the same time. Therefore, this innovation would solve a problem for healthcare providers of having broad and comprehensive testing solutions most desired in an outbreak of respiratory illness.
- Investment on R&D: Newer advanced technologies meant for diagnostics research will attract more investments in R&D. Thus, they can open up new avenues in the rapid influenza diagnostic tests market, focusing more on the precision, quick detection, and easy handling of tests results for the attraction of healthcare providers to provide better public health management at the time of flu seasons.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Rapid Influenza Diagnostic Tests Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Rapid Influenza Diagnostic Tests Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The rapid influenza diagnostic tests market is estimated to grow with a CAGR of 8.4% from 2023 to 2031.
Asia-Pacific region is likely to witness the fastest growth rate during the forecast period
The rapid influenza diagnostic tests market majorly consists of players such as DiaSorin S.p.A, Becton Dickinson and Company, SA Scientific among others.
The market drivers include rising prevalence of influenza infections and innovations in diagnostic technology are driving the rapid influenza diagnostic tests market.
Shift towards point-of-care (POC) testing is a significant trend in the rapid influenza diagnostic tests market is likely to remain the key trend during the forecast period.
North America dominated the rapid influenza diagnostic tests market in 2023.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Rapid Influenza Diagnostic Tests (RIDT) Market - By Product
1.3.2 Rapid Influenza Diagnostic Tests (RIDT) Market - By Patient
1.3.3 Rapid Influenza Diagnostic Tests (RIDT) Market - By End User
1.3.4 Rapid Influenza Diagnostic Tests (RIDT) Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) MARKET - GLOBAL MARKET ANALYSIS
6.1. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) - GLOBAL MARKET OVERVIEW
6.2. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. RIDT FOR INFLUENZA A
7.3.1. Overview
7.3.2. RIDT for Influenza A Market Forecast and Analysis
7.4. RIDT FOR INFLUENZA B
7.4.1. Overview
7.4.2. RIDT for Influenza B Market Forecast and Analysis
8. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) MARKET - REVENUE AND FORECASTS TO 2028 - PATIENT
8.1. OVERVIEW
8.2. PATIENT MARKET FORECASTS AND ANALYSIS
8.3. PEDIATRIC
8.3.1. Overview
8.3.2. Pediatric Market Forecast and Analysis
8.4. ADULT
8.4.1. Overview
8.4.2. Adult Market Forecast and Analysis
9. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTICS CENTERS
9.4.1. Overview
9.4.2. Diagnostics Centers Market Forecast and Analysis
9.5. RESEARCH LABORATORIES
9.5.1. Overview
9.5.2. Research Laboratories Market Forecast and Analysis
10. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Rapid Influenza Diagnostic Tests (RIDT) Market Overview
10.1.2 North America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis
10.1.3 North America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Product
10.1.4 North America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Patient
10.1.5 North America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By End User
10.1.6 North America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Countries
10.1.6.1 United States Rapid Influenza Diagnostic Tests (RIDT) Market
10.1.6.1.1 United States Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.1.6.1.2 United States Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.1.6.1.3 United States Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.1.6.2 Canada Rapid Influenza Diagnostic Tests (RIDT) Market
10.1.6.2.1 Canada Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.1.6.2.2 Canada Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.1.6.2.3 Canada Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.1.6.3 Mexico Rapid Influenza Diagnostic Tests (RIDT) Market
10.1.6.3.1 Mexico Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.1.6.3.2 Mexico Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.1.6.3.3 Mexico Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.2. EUROPE
10.2.1 Europe Rapid Influenza Diagnostic Tests (RIDT) Market Overview
10.2.2 Europe Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis
10.2.3 Europe Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Product
10.2.4 Europe Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Patient
10.2.5 Europe Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By End User
10.2.6 Europe Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Rapid Influenza Diagnostic Tests (RIDT) Market
10.2.6.1.1 Germany Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.2.6.1.2 Germany Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.2.6.1.3 Germany Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.2.6.2 France Rapid Influenza Diagnostic Tests (RIDT) Market
10.2.6.2.1 France Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.2.6.2.2 France Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.2.6.2.3 France Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.2.6.3 Italy Rapid Influenza Diagnostic Tests (RIDT) Market
10.2.6.3.1 Italy Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.2.6.3.2 Italy Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.2.6.3.3 Italy Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.2.6.4 Spain Rapid Influenza Diagnostic Tests (RIDT) Market
10.2.6.4.1 Spain Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.2.6.4.2 Spain Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.2.6.4.3 Spain Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.2.6.5 United Kingdom Rapid Influenza Diagnostic Tests (RIDT) Market
10.2.6.5.1 United Kingdom Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.2.6.5.2 United Kingdom Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.2.6.5.3 United Kingdom Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.2.6.6 Rest of Europe Rapid Influenza Diagnostic Tests (RIDT) Market
10.2.6.6.1 Rest of Europe Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.2.6.6.2 Rest of Europe Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.2.6.6.3 Rest of Europe Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market Overview
10.3.2 Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis
10.3.3 Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Patient
10.3.5 Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Rapid Influenza Diagnostic Tests (RIDT) Market
10.3.6.1.1 Australia Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.3.6.1.2 Australia Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.3.6.1.3 Australia Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.3.6.2 China Rapid Influenza Diagnostic Tests (RIDT) Market
10.3.6.2.1 China Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.3.6.2.2 China Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.3.6.2.3 China Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.3.6.3 India Rapid Influenza Diagnostic Tests (RIDT) Market
10.3.6.3.1 India Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.3.6.3.2 India Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.3.6.3.3 India Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.3.6.4 Japan Rapid Influenza Diagnostic Tests (RIDT) Market
10.3.6.4.1 Japan Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.3.6.4.2 Japan Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.3.6.4.3 Japan Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.3.6.5 South Korea Rapid Influenza Diagnostic Tests (RIDT) Market
10.3.6.5.1 South Korea Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.3.6.5.2 South Korea Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.3.6.5.3 South Korea Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.3.6.6 Rest of Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market
10.3.6.6.1 Rest of Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.3.6.6.2 Rest of Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.3.6.6.3 Rest of Asia-Pacific Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Rapid Influenza Diagnostic Tests (RIDT) Market Overview
10.4.2 Middle East and Africa Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis
10.4.3 Middle East and Africa Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Patient
10.4.5 Middle East and Africa Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Rapid Influenza Diagnostic Tests (RIDT) Market
10.4.6.1.1 South Africa Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.4.6.1.2 South Africa Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.4.6.1.3 South Africa Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.4.6.2 Saudi Arabia Rapid Influenza Diagnostic Tests (RIDT) Market
10.4.6.2.1 Saudi Arabia Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.4.6.2.2 Saudi Arabia Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.4.6.2.3 Saudi Arabia Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.4.6.3 U.A.E Rapid Influenza Diagnostic Tests (RIDT) Market
10.4.6.3.1 U.A.E Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.4.6.3.2 U.A.E Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.4.6.3.3 U.A.E Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market Overview
10.5.2 South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis
10.5.3 South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Product
10.5.4 South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Patient
10.5.5 South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By End User
10.5.6 South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Rapid Influenza Diagnostic Tests (RIDT) Market
10.5.6.1.1 Brazil Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.5.6.1.2 Brazil Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.5.6.1.3 Brazil Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.5.6.2 Argentina Rapid Influenza Diagnostic Tests (RIDT) Market
10.5.6.2.1 Argentina Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.5.6.2.2 Argentina Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.5.6.2.3 Argentina Rapid Influenza Diagnostic Tests (RIDT) Market by End User
10.5.6.3 Rest of South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market
10.5.6.3.1 Rest of South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market by Product
10.5.6.3.2 Rest of South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market by Patient
10.5.6.3.3 Rest of South and Central America Rapid Influenza Diagnostic Tests (RIDT) Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. RAPID INFLUENZA DIAGNOSTIC TESTS (RIDT) MARKET, KEY COMPANY PROFILES
13.1. DIASORIN S.P.A
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BECTON, DICKINSON AND COMPANY
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SA SCIENTIFIC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CORISBIOCONCEP
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. MERIDIAN BIOSCIENCE INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ABBOTT
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ANALYTIK JENA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ROCHE
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. QUIDEL CORPORATION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PRINCETON BIOMEDITECH CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. DiaSorin S.p.A
2. Becton Dickinson and Company
3. SA Scientific
4. CorisBioconcep
5. Meridian Bioscience Inc.
6. Abbott
7. Analytik Jena
8. Roche
9. Quidel Corporation
10. Princeton BioMeditech Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.